Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.
During the past 25 years, 24 randomized trials of intravenous (IV) fibrinolytic treatment have been reported, involving a total of some 6000 patients in the acute phase of myocardial infarction. Most tested IV streptokinase (SK), but a few tested IV urokinase (UK). In the past 2 or 3 years numerous...
Main Authors: | Yusuf, S, Collins, R, Peto, R, Furberg, C, Stampfer, M, Goldhaber, S, Hennekens, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1985
|
Similar Items
-
INTRAVENOUS STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION - REPLY
by: Stampfer, M, et al.
Published: (1983) -
Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials.
by: Stampfer, M, et al.
Published: (1982) -
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
by: Collins, R, et al.
Published: (1997) -
Long-Term Predictors of Hospitalized Reinfarction after an Incident Acute Myocardial Infarction
by: Timo Schmitz, et al.
Published: (2022-12-01) -
Risk factors for myocardial reinfarction in young and middle-aged males
by: Vladimir Vladimirovich Yakovlev, et al.
Published: (2010-09-01)